Final Phase 1b results presented at World Lung Conference highlight the potential of firmonertinib to address unmet needs in EGFR PACC mutant ...
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 15 stocks set to explode in 2026. On November 7, 2025, Summit ...
Weakened lung function diagnosis can potentially be achieved sooner in the aging process with increased monitoring.
Avenzo Therapeutics Granted Fast Track Designation for AVZO-1418, a Potential Best-in-Class EGFR/HER3 Bispecific Antibody-Drug Conjugate ...
According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...
Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a ...
SurvivorNet on MSN
A Chicago Grandmother’s Seven-Year Journey with Small-Cell Lung Cancer: A Fight for Time, Hope, and Progress
Maida Mangiameli, 75, has defied the odds by surviving over seven years with small-cell lung cancer—a disease with a ...
Circ-EGFR was identified as a novel predictive biomarker for cetuximab efficacy in KRAS wild-type metastatic colorectal ...
Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...
Expert discusses how the prevalence of chronic kidney disease (CKD), as reflected by decreased estimated glomerular ...
Expert discusses how understanding and promoting awareness of CKD stages enables earlier intervention and better management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback